Te­va launch­es Ste­lara biosim­i­lar at 85% dis­count as wider field emerges

Te­va and its part­ner Alvotech on Fri­day fol­lowed Am­gen in launch­ing a biosim­i­lar to John­son & John­son’s block­buster im­muno­sup­pres­sive bi­o­log­ic Ste­lara, of­fer­ing a steep dis­count …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER